Indigo Diabetes
Indigo Diabetes is a medtech company that develops a multi-biomarker sensor for people with diabetes.
Indigo Diabetes has raised €38M across 1 funding round from 1 investor, most recently a Series B round in Jul 2020. Based in Zwijnaarde, Belgium; founded 2016; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€38M
€38,000,000
Funding rounds
1
Investors
1
distinct backers
Active since
2020-07
latest 2020-07
Funding by year
EUR raised per yearIndigo Diabetes — funding by year — interactive chart.
Data table
| Indigo Diabetes — funding by year | |
|---|---|
| 2020 | €38M |
Signals
High confidenceRaise-next likelihood9
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-07-27 | Series B | €38M | Fund+ | View deal → |
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Imec€2.5BBelgium · Deeptech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Kpler€1.0BBelgium · Software
Global coverage: FundingData